Page 1 of Clinical Trials for OROS®, 108 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Last Updated: April 24, 2012
Condition(s): Attention Deficit Disorder With Hyperactivity
2
Completed
An Effectiveness and Safety Study Evaluating OROS Methylphenidate Hydrochloride (HCl), Ritalin (Methylphenidate HCl) and Placebo in Children With Attention Deficit Hyperactivity Disorder
Last Updated: July 8, 2011
Condition(s): Attention Deficit Hyperactivity Disorder
3
Completed
A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
Last Updated: June 6, 2011
Condition(s): Schizophrenia
4
Completed
A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese Volunteers
Last Updated: June 6, 2011
Condition(s): Schizophrenia
5
Completed
A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone
Last Updated: May 17, 2011
Condition(s): Schizophrenia
6
Completed
Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory
Last Updated: November 15, 2011
Condition(s): Attention Deficit Hyperactivity Disorder
7
Completed
A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function
Last Updated: June 9, 2011
Condition(s): Schizophrenia; Renal Impairment
8
Completed
Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)
Last Updated: March 16, 2009
Condition(s): Methamphetamine Dependence; Methamphetamine Abuse
9
Completed
Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain
Last Updated: March 20, 2012
Condition(s): Chronic Low Back Pain
10
Active, not recruiting
Study Examining Repeat Dosing of OROS® Methylphenidate (CONCERTA®) and Immediate Release Methylphenidate in Healthy Adults
Last Updated: July 5, 2011
Condition(s): Healthy
11
Completed
Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD
Last Updated: January 3, 2011
Condition(s): Attention Deficit Hyperactivity Disorder
12
Completed
A Study of Dopamine Type 2 (D2) Receptor Occupancy Following a Single Oral Dose of OROS Paliperidone
Last Updated: June 8, 2011
Condition(s): Schizophrenia
13
Completed
Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Last Updated: May 18, 2011
Condition(s): Attention Deficit Disorder With Hyperactivity
14
Completed
A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS Paliperidone
Last Updated: June 6, 2011
Condition(s): Schizophrenia
15
Completed
This is a Randomised, Open-labeled, Multi-center Study to Investigate the Safety and Efficacy of OROS Hydromorphone HCL Comparing With Morphine SR (Sustain Release) in Cancer Pain Patients.
Last Updated: August 5, 2010
Condition(s): Pain
16
Completed
A Dose-proportionality Study of Five Tablet Strengths of ER OROS Paliperidone
Last Updated: May 20, 2011
Condition(s): Schizophrenia
17
Completed
A Bioequivalence Study of 15 mg ER OROS Paliperidone
Last Updated: June 6, 2011
Condition(s): Schizophrenia
18
Completed
Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
Last Updated: April 26, 2010
Condition(s): Pain
19
Completed
A Study to Evaluate Effectiveness and Safety of Prolonged Release OROS Methylphenidate in Adults With Attention Deficit Hyperactivity Disorder
Last Updated: July 13, 2010
Condition(s): Attention Deficit/ Hyperactivity Disorder
20
Completed
An Open Label Phase I/II Study of Dopamine Transporter Receptor Occupancy With OROS and Immediate Release Methylphenidate as Measured With C-11 Altropane in Human Subjects
Last Updated: July 11, 2011
Condition(s): Healthy Volunteers

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=OROS%C2%AE

Page 1 of Clinical Trials for OROS®, 108 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About